The broader market sell-off saw the S&P 500 drop 1.25% to 7,646.79, while the Nasdaq Composite fell 0.90% to 26,825.83. Small caps faced the most significant pressure, with the Russell 2000 retreating 1.16% to 2,804.63. With an RSI14 of 32, the small-cap index is currently hovering near oversold territory, reflecting deep investor caution. Volatility remains contained but elevated, as the VIX closed at 16.96.

Corporate results offered a mixed landscape this week. McCormick & Company posted a 17.4% jump in net sales, with CEO Brendan M. Foley citing the resilience of their flavor-focused business model. Conversely, Conagra Brands reported a 1.4% decline in net sales for the first quarter of fiscal 2027, reaffirming its cautious annual guidance. Meanwhile, Recon Technology saw revenue surge 65.8% to RMB109.9 million, driven by overseas expansion, and RedHill Biopharma moved to bolster its portfolio by acquiring commercialization rights for Rebyota and Clenpiq. As the earnings gauntlet intensifies, the rise in Treasury yields continues to weigh on rate-sensitive sectors, leaving market participants searching for a stable footing.